Arena Pharma (ARNA) Tops Q4 Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to Arena Pharma (ARNA) Tops Q4 Views

Arena Pharma (ARNA) PT Raised to $63 at Credit Suisse

February 27, 2019 8:02 AM EST

Credit Suisse analyst Martin Auster raised the price target on Arena Pharma (NASDAQ: ARNA) to $63.00 (from $61.00) while maintaining a Outperform rating.

... More

Arena Pharma (ARNA) PT Raised to $79 at RBC Capital

February 27, 2019 6:43 AM EST

RBC Capital analyst Kennen MacKay raised the price target on Arena Pharma (NASDAQ: ARNA) to $79.00 (from $70.00) while maintaining a Outperform rating.

Flush with cash, ARNA positions to execute in the clinic in 2019, MacKay comments.

... More